期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
The BRAF^V600E mutation improve diagnostic sensitivity of thyroid nodules with benign or indeterminate cytology results
1
作者 Zhang Wei Ye Danrong +1 位作者 Wang Qingxuan Zhang Xiaohua 《中华内分泌外科杂志》 CAS 2019年第6期476-482,共7页
Objective To investigate the role of BRAF^V600E mutation in diagnosis of thyroid nodules when it is inconsonant with cytological results.Methods This study included 9837 patients who underwent US-FNA.We mainly analyze... Objective To investigate the role of BRAF^V600E mutation in diagnosis of thyroid nodules when it is inconsonant with cytological results.Methods This study included 9837 patients who underwent US-FNA.We mainly analyzed 239 cases with benign or indeterminate cytology,but having a detection of BRAF^V600E mutation.BRAF^V600E mutation analysis was performed using a Amplification Refractory Mutation System Polymerase Chain Reaction.Results In 93 nodules with benign cytology results but positive BRAF^V600E mutation,84 nodules were malignant.Based on the results,US-FNA combined with BRAF^V600E mutation analysis will improve sensitivity(Se=94.03%)and negative predictive value(NPV=2.69%)of the thyroid nodules diagnosis than using US-FNA alone(Se=71.03%,NPV=20.76%).Conclusion BRAFV600E mutation analysis is an important tool in the diagnosis of PTC with high sensitivity and NPV.When facing patients with benign or indeterminate cytology but positive BRAF^V600E mutation,thyroidectomy should be considered. 展开更多
关键词 Thyroid cancer BRAF^V600E mutation Benign cytology indeterminate cytology
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部